XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (473,069) $ (1,662,404)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 230,208 182,795
Accretion of asset retirement obligation 2,516 2,498
Stock based compensation $ 0 $ 614,431
Issuance of common stock for services 32,326 2,300
Equity income on investment in Buckskin $ (331) $ 0
Change in operating assets and liabilities:    
Gold sales receivable (398,230) 155,622
Inventories (392,351) 96,961
Joint venture receivable 1,614 1,708
Other current assets 36,715 26,353
Accounts payable and accrued expenses 64,907 (142,954)
Accrued payroll and related payroll expenses 47,609 3,523
Net cash used by operating activities (848,086) (719,167)
Cash flows from investing activities:    
Purchases of property, plant, and equipment 66,818 57,111
Deposits on equipment 29,891 7,953
Additions to mineral property 192,112 140,716
Net cash used by investing activities (288,821) (189,874)
Cash flows from financing activities:    
Proceeds from sale of common stock net of issuance cost (2,701,000) 0
Proceeds from exercise of common stock warrants 68,006 0
Principal payments on notes payable (192,054) (111,934)
Principal payments on notes payable, related parties 10,203 9,063
Issuance of convertible debt 0 1,600,000
Contributions from non-controlling interest 2,828 2,469
Net cash provided by financing activities 2,569,577 1,481,472
Net change in cash and cash equivalents 1,432,670 572,431
Cash and cash equivalents, beginning of period 1,976,518 2,539,945
Cash and cash equivalents, end of period 3,409,188 3,112,376
Notes payable for equipment purchase 241,861 $ 761,073
Deposit on equipment paid by lender 96,000  
Conversion of convertible debt to common stock $ 1,950,000